This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 11/28/2022
Location: Virtual
Subject: Naloxone Access and Harm Reduction
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several state, local, territorial, tribal health departments, and harm reduction organizations

Event Date: 12/02/2022
Location: Virtual
Subject: Integrated Food Safety System
FDA Participant/Group: JANET WOODCOCK; TRISTAN COLONIUS; MELISSA SAFFORD; JULIA TIERNEY;
Non FDA Participant/Group: Steven Mandernach (Association of Food and Drug Officials); Elisabeth Wirsing (Vermont Department of Health); Natalie Adan (Georgia Department of Agriculture); Katherine Simon (Minnesota Department of Agriculture);

Event Date: 12/03/2022
Location: Washington, DC
Subject: Global CardioVascular Clinical Trialists Forum
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, media, and other registered attendees

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 12/01/2022
Location: Virtual
Subject: Equitable Breakthroughs in Medicine Development (EQBMED) Executive Committee Meeting
FDA Participant/Group: RICHARDAE ARAOJO; LAURA HARRIS;
Non FDA Participant/Group: Members from academia, industry, and other stakeholders

Event Date: 12/02/2022
Location: Virtual
Subject: Accelerating Medicines Partnership (AMP) Extended Executive Committee Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members from government agencies, industry, and other stakeholders

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 12/02/2022
Location: Virtual
Subject: National Biodefense
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives of the Bipartisan Commission on Biodefense

Event Date: 12/02/2022
Location: Virtual
Subject: Listening Session Regarding Various FDA Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives of Arnold Ventures

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 11/28/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: DONALD PRATER;
Non FDA Participant/Group: Adam Van Opzeeland, Bill Jolly, Vincent Arbuckle (Ministry for Primary Industries, New Zealand Food Safety);

Event Date: 11/29/2022
Location: Virtual
Subject: Webinar; Tech-Enabled Traceability: New Standards to Improve Food System Transparency
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the food industry, academia, and government

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

Event Date: 12/01/2022
Location: Virtual
Subject: CVM Roundtable Stakeholder Discussion
FDA Participant/Group: TRACEY FORFA; STEVEN SOLOMON; ELIZABETH MILLER;
Non FDA Participant/Group: Alex Sullivan, Lee Ann McNee, Susan Winckler (Reagan Udall);

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 12/02/2022
Location: Virtual
Subject: FDA / American Association of Tissue Banks Liaison Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the American Association of Tissue Banks

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 11/30/2022
Location: Silver Spring, MD
Subject: Patient Safety, Quality Improvement, and Regulatory Science of Artificial Intelligence (AI) Enabled Products
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Cassie Scherer, Chris Hedrich, Geoff Martha, Jennifer Doyle, Laura Mauri, Malia Lowe, Noel Colon, Olaf Harrold, Que Dallara, Sandy Kalter, Yarmela Pavlovic (Medtronic);

Event Date: 12/01/2022
Location: Virtual
Subject: Mammography Quality Standards Act and Program
FDA Participant/Group: DAVID LEE; ELLEN FLANNERY; DAVID LERNER; BINITA ASHAR; WILLIAM MAISEL; TERRI CORNELISON; ROBERT OCHS; LAURIE STERNBERG;
Non FDA Participant/Group: Aracely Panameno , Molly Guthrie (Susan G. Komen Breast Cancer Foundation); Johanna Gray (Artemis Policy Group);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 12/01/2022
Location: Virtual
Subject: Quarterly Meeting with Nutrition Consumer and Public Health Stakeholders; Covid 19 Updates, FDA Coalition Nutrition Priorities, and Closer to Zero Updates
FDA Participant/Group: CHRISTOPHER WALDROP; JANESIA ROBBS; CLAUDINE KAVANAUGH; LINDSAY HAAKE; CONRAD CHOINIERE; JENNIFER DOOREN; EMILY ROSE CAREY; KARI BARRETT; ROBIN MCKINNON; DOUGLAS BALENTINE;
Non FDA Participant/Group: Michelle Futrell, Sara Rogers (Association of State Public Health Nutritionist); John Patton (Center for Partnerships & Innovation, National Association of Chronic Disease); Funke Ajenikoko, Susan Bishop (American Heart Association); Madison West (Trust for America's Health); Madeline Curtis (Department of Federal Affairs, American Academy of Pediatrics); Fran Flemming (Rudd Center for Food Policy and Health); Eva Greenthal, Jacob Multer, Peter Lurie (Center for Science in the Public Interest ); Mollie Van Lieu (International Fresh Produce Association ); Christy Cushing (American Cancer Society Action Network); Brian Ronholm (Consumer Reports);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 11/29/2022
Location: Virtual
Subject: Introductory Meeting with Counter Tools
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from Counter Tools

Event Date: 11/30/2022
Location: Virtual
Subject: Premarket Tobacco Product Applications (PMTA) Review and Enforcement
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Legislative staff members of Representative Tim Kaine (D-VA)

Event Date: 12/01/2022
Location: Washington, DC
Subject: Introductory Meeting and Program Update
FDA Participant/Group: BRIAN KING;
Non FDA Participant/Group: Senator Richard Burr (R-NC)

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 11/29/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Dana Brooks (Pet Food Institute);

Event Date: 12/02/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Constance Cullman (American Feed Industry Association);

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event